NCT00400270 Breathing and Relaxation Exercises for Asthma: a Randomised Controlled Trial Status COMPLETED Phase NA
NCT00399984 Evaluating a Pediatric Asthma Management Education Program for Physicians Status COMPLETED Phase NA
NCT00398645 A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. Status COMPLETED Phase PHASE2
NCT00398151 To Evaluate the Inflammatory Markers in Adult Patients With Asthma Associated With Allergic Rhinitis Receiving Montelukast Therapy (0476-366) Status COMPLETED Phase PHASE3
NCT00395304 Childhood Asthma Research and Education (CARE) Network Trial - Best Add-On Therapy Giving Effective Response (BADGER) Status COMPLETED Phase PHASE3
NCT00395096 Environmental Exposures, Genetics, and Exhaled Nitric Oxide in Pediatric Asthma Status COMPLETED Phase N/A
NCT00394914 Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295) Status COMPLETED Phase PHASE2
NCT00394654 A Study to Evaluate the Efficacy of MEDI-528 on Late Asthmatic Response With Atopic Asthma Status COMPLETED Phase PHASE2
NCT00394355 Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418) Status COMPLETED Phase PHASE4
NCT00394329 (CARE Network Trial - Treating Children to Prevent Exacerbations of Asthma (TREXA) Status COMPLETED Phase PHASE3
NCT00394199 Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone & Formoterol Administered Alone in Patients With Asthma Status COMPLETED Phase PHASE3
NCT00394121 New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) in Patients With Asthma Status COMPLETED Phase PHASE3
NCT00393991 Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma Status COMPLETED Phase PHASE3
NCT00393952 New Combination Inhaler (FlutiForm HFA MDI 100/10 µg and 250/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo in Patients With Moderate to Severe Asthma Status COMPLETED Phase PHASE3
NCT00393367 Budesonide Inhalation Suspension for Acute Asthma in Children Status COMPLETED Phase PHASE4
NCT00392288 Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma. Status COMPLETED Phase PHASE3
NCT00389363 Efficacy and Safety Trial of the ALK HDM Tablet in House Dust Mite Allergic Subjects Status COMPLETED Phase PHASE2/PHASE3
NCT00388739 Initiation of Chronic Asthma Care Regimens in the Pediatric Emergency Department Status WITHDRAWN Phase NA